ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,437 | -59.2% | 4,887 | -63.4% | 0.06% | -70.7% |
| Q3 2022 | $553,000 | +41.1% | 13,355 | +147.7% | 0.22% | -1.4% |
| Q1 2022 | $392,000 | -23.3% | 5,392 | +0.5% | 0.22% | -53.1% |
| Q2 2021 | $511,000 | +150.5% | 5,364 | +66.9% | 0.46% | +244.4% |
| Q2 2019 | $204,000 | -61.6% | 3,214 | -71.9% | 0.14% | -12.9% |
| Q4 2017 | $531,000 | +149.3% | 11,453 | +186.3% | 0.16% | +158.3% |
| Q3 2017 | $213,000 | -27.1% | 4,000 | +53.8% | 0.06% | -73.5% |
| Q4 2015 | $292,000 | – | 2,600 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |